| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6573877038398618 4.064956998790489 4.8041318621905305e-05 0.0279471065371221 0.0141721889934623 49 P00846,O75438,P36542,O43674,P12236,Q9Y6M9,P51970,Q9UDW1,O43676,P06576,O95168,P31930,P12235,O75880,O14949,O75964,P14406,O96000,P24539,P00403,P03886,P25705,P05141,O95139,P22695,P21912,P13073 27 |
| Nonalcoholic fatty liver disease 0.5867068786478266 3.4701718976487 0.000520125374033 0.2643154148051255 0.1022913235598253 47 P31751,Q9P0J0,O75438,O43674,Q9Y6M9,P51970,Q9UDW1,O43676,O95168,P31930,O14949,P14406,O96000,P00403,O95139,P22695,Q86Y39,P21912,P13073 19 |
| Mitochondrial complex i assembly model oxphos system 0.6417589591283348 3.106300099446702 0.0018944434796928 0.6733224637507272 0.2020206904087722 27 Q9P0J0,O75438,O96000,O95139,O43676,Q96CU9,O43674,P03886,Q9Y6M9,Q8IUX1,Q8TB37,Q7L592 12 |
| Oxidative phosphorylation 0.5787651987568101 2.854531947327279 0.0043100296577118 0.921794345048614 0.2224197564369614 32 P00846,O75438,O43674,Q9Y6M9,P51970,P06576,O95168,O75947,O75964,O96000,P24539,P03886,P56385,O00483,P25705,O95139,Q15904,Q86Y39,O75787 19 |
| Mitochondrial complex iv assembly 0.8289659598101929 2.6081243089684603 0.0091039886260619 0.995465103766585 0.3111096372968024 10 P14406,Q9Y2R0,Q8N8Q8,P00403,P13073 5 |
| Sphingolipid metabolism overview 0.7474028774338872 2.2897913621494856 0.0220334141330547 0.9999980448965172 0.382344539367714 11 Q06136,P27544,O95470,O15269,O15121,Q16739,Q96G23,Q13510 8 |
| Sphingolipid metabolism integrated pathway 0.7474028774338872 2.2897913621494856 0.0220334141330547 0.9999980448965172 0.382344539367714 11 Q06136,P27544,O95470,O15269,O15121,Q16739,Q96G23,Q13510 8 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6972125052375249 2.212798586041341 0.0269115348173372 0.9999998977009792 0.4143541481078986 13 P50402,O75844,P42167,O60725 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8267570773362207 2.2059212868991662 0.0273895114850983 0.9999999234439184 0.4143541481078986 5 Q16850,Q15392 2 |
| Mitochondrial complex iii assembly 0.755071673379307 2.162884251538607 0.0305500833323457 0.999999988780518 0.4390424796381035 9 O14949,Q9UDW1,Q6DKK2,Q9BRT2,P22695,P08574,P31930 7 |
| Oxidation by cytochrome p450 0.7911973002387269 2.1333079505924735 0.0328994724396247 0.9999999973192524 0.4390424796381035 6 O43169,Q16850,Q6UW02 3 |
| Omega3 omega6 fatty acid synthesis 0.7893900549117462 2.125012211877285 0.0335855939270146 0.9999999982363874 0.4390424796381035 6 O15254,O95573,Q15067,O95864 4 |
| Familial partial lipodystrophy fpld 0.7317107515863015 1.976541947619867 0.0480934296943416 0.9999999999997652 0.4460650017198175 8 P31751,P20700,O60725,O75844,Q03252 5 |
| Sphingolipid pathway 0.6827412851567458 1.9480586831868336 0.0514079418211119 0.99999999999997 0.4460650017198175 11 P04062,Q06136,O95470,O15269,Q16739,Q96G23,Q13510 7 |
| Metabolism of spingolipids in er and golgi apparatus 0.7506738544474274 1.9454482121417849 0.0517210569377064 0.9999999999999754 0.4460650017198175 6 Q06136,Q10472,Q16880,O95470,Q16739 5 |
| Glycerophospholipid biosynthetic pathway 0.7019912061942375 1.8959963344469908 0.057960529230181 0.9999999999999994 0.4460650017198175 9 Q86UL3,Q9HCL2,O14735,O00116,O95674,Q8WUK0 6 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7544224673658988 1.8780836072361229 0.0603697284930704 1.0 0.4460650017198175 5 Q03252,P20700,O60725 3 |
| Omega9 fatty acid synthesis 0.7304731209678033 1.8503791019557472 0.0642589288789792 1.0 0.4601464280828841 6 O00767,O95864,O95573 3 |
| Mitochondrial immune response to sarscov2 0.6924099836648786 1.8470193314067536 0.0647443386142319 1.0 0.4601464280828841 9 P35232,Q7Z434,Q86UT6,Q99623,Q9Y276,Q9Y6M9,Q9BQ95 7 |
| Sphingolipid metabolism in senescence 0.6315834883183796 1.8388977563838689 0.0659302258779022 1.0 0.4601464280828841 13 O15269,P05771,O15121,Q16739,Q96G23,P04062 6 |
| Influence of laminopathies on wnt signaling 0.689521736424129 1.832208424199356 0.0669203742634516 1.0 0.4601464280828841 9 O75844,O60725 2 |
| Copper homeostasis 0.7198858708095998 1.8001859088224497 0.0718312880751774 1.0 0.4761849434197158 6 O43819,Q8N668,P35670,O75880 4 |
| Proteoglycan biosynthesis 0.8272727272727365 1.7596809833420213 0.0784619119047878 1.0 0.4822138335815084 4 Q9NX62,Q8NCH0,Q8TB61 3 |
| Metapathway biotransformation phase i and ii 0.4862213102371304 1.7184091585242574 0.0857220109983534 1.0 0.5022049168102806 20 Q99735,P78417,Q6UW02,Q7LGA3,Q16850,Q8NCH0,P21964 7 |
| Triacylglyceride synthesis 0.7012462108454018 1.6302747269521345 0.1030434465311249 1.0 0.5332950302926642 5 O15228,O00116,Q9NUQ2,Q9HCL2 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4622754640909703 1.6022794082436964 0.1090938370844649 1.0 0.5454691854223248 24 O00767,Q15800,Q15392,Q14534,P14324,P33121,P37268,O95864,Q16850,P35610,Q14739,O95573 12 |
| Ferroptosis 0.4564461140479954 1.5764317442251718 0.1149263374226639 1.0 0.5650544923280975 25 P16435,P45880,Q9NZ45,P37268,Q15043,P09601,P04792,O95573,Q9Y277 9 |
| Nanomaterial induced apoptosis 0.6786675646314213 1.5235373631669011 0.1276243203908635 1.0 0.5904550537475071 5 O95831 1 |
| Zinc homeostasis 0.9087849209020484 1.4651987741360195 0.1428666939652099 1.0 0.5992969850019977 3 Q6NXT4,Q8TAD4 2 |
| Ppar signaling pathway 0.5055801975400361 1.346311417532394 0.1782021051954512 1.0 0.6612530947504164 16 O00767,O15254,P33121,O95864,P23786,O95573,Q15067 7 |
| Glycerolipids and glycerophospholipids 0.6144908463011437 1.2885082836098392 0.1975690871920403 1.0 0.6979985715167893 6 O14735,Q9UG56,Q86UL3,Q9HCL2 4 |
| Endothelin pathways 0.6105868260033258 1.2692258995324626 0.2043605062380047 1.0 0.7103385498593269 6 P16615,P00403 2 |
| Amyotrophic lateral sclerosis als 0.5536951144685736 1.2314173867402929 0.2181667974304701 1.0 0.7138431827049159 11 P07197,Q9BUN8,O96008 3 |
| Ketogenesis and ketolysis 0.5971474312865458 1.202744561908694 0.2290751838292157 1.0 0.7138431827049159 6 P23786 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.8398073993682968 1.1924768044580445 0.233074340560105 1.0 0.7138431827049159 3 Q9BXK5 1 |
| Progeriaassociated lipodystrophy 0.5570014254625257 1.1882845623252691 0.2347213177029723 1.0 0.7138431827049159 10 O60725 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5135298975627024 1.1340679825622753 0.2567660326348908 1.0 0.7454006981836933 13 P40939,Q16836,P33121,Q9BY49,P23786,O95573 6 |
| Tryptophan metabolism 0.4990806617936323 1.1216216542468909 0.2620233405944692 1.0 0.7506202858497915 14 Q15392,P40939,Q16836,P51648,P35610,P30084 6 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5229847271758628 1.1199881716172166 0.2627188026457041 1.0 0.7506202858497915 12 P07237,Q5JRA6,Q96AY3,Q32P28,O75718,P13674 6 |
| Fatty acid betaoxidation 0.4249667537035431 1.100593946583979 0.2710734213143375 1.0 0.75086065058901 19 P43304,P40939,P09622,Q16836,P33121,P23786,P35610,O95573,P30084 9 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5428576543822452 1.0572461583468198 0.2903992587703601 1.0 0.7752740392511877 9 Q9NR77,O95140,P07196,P04792,Q8TB36,P51149 6 |
| Cellular proteostasis 0.6529883271736844 1.0181129098509365 0.3086243008496354 1.0 0.7818827212684091 4 O15212,P61758 2 |
| Nocgmppkg mediated neuroprotection 0.6482871075999413 0.998128260457552 0.3182171679312069 1.0 0.7898135472209301 4 P30536,Q13555 2 |
| Statin inhibition of cholesterol production 0.5457236136320772 0.9479162295955786 0.3431721020192713 1.0 0.8266831282793148 6 Q8WTV0,P37268,Q14534 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.5322919633883757 0.8816242413742126 0.3779800415334473 1.0 0.8470660065756201 6 Q15418 1 |
| Urea cycle and related diseases 0.884253028263801 0.8815607157231992 0.3780144069173383 1.0 0.8470660065756201 2 Q9Y619 1 |
| Vitamin b12 disorders 0.618016665596232 0.8703325437606986 0.3841186990355854 1.0 0.8470660065756201 4 Q99707 1 |
| G1 to s cell cycle control 0.3782442140044431 0.8691429159700947 0.3847689656987563 1.0 0.8470660065756201 22 Q14566,Q9Y619 2 |
| Vitamin d metabolism 0.7495792662403112 0.8425056299893854 0.3995049896738079 1.0 0.8643147143792284 3 P38435,P04062 2 |
| Glycosylation and related congenital defects 0.4850938258528707 0.8409401037096474 0.4003814901544493 1.0 0.8643147143792284 11 Q2TAA5,Q9BT22,Q9H0U3,Q9BV10,Q9H3H5 5 |
| Apoptosis modulation and signaling 0.483488417521229 0.8318604696073743 0.4054877070184153 1.0 0.8643147143792284 11 Q07820,O95831 2 |
| Irinotecan pathway 0.8697846567967753 0.8305474192563772 0.406229349167635 1.0 0.8643147143792284 2 P33527 1 |
| Allograft rejection 0.4981507786074905 0.8179351659725715 0.4133942089572175 1.0 0.8648131773911548 9 P04439,P08670,Q9BY49,P10321,P08183 5 |
| Adipogenesis 0.4457762225663939 0.7235662773669542 0.4693320508832166 1.0 0.8990451624061617 13 Q9NZ45,O75844,P43490 3 |
| Ccl18 signaling pathway 0.4770849737978973 0.7066667385386245 0.4797736041981195 1.0 0.9072641874259312 9 P08670,P00403,Q86UE4 3 |
| Histone modifications 0.5619155669487675 0.640424608006482 0.5218965888186604 1.0 0.9403657567164786 4 Q01105,Q03164 2 |
| Nephrotic syndrome 0.4515082232063557 0.6105727688039058 0.5414824549889992 1.0 0.9403657567164786 10 O75844,Q9BT22 2 |
| Nuclear receptors in lipid metabolism and toxicity 0.8018169582772592 0.6017904380987128 0.5473136407834007 1.0 0.9403657567164786 2 P08183 1 |
| 22q112 copy number variation syndrome 0.3380426725076043 0.5907674846602464 0.5546762240592145 1.0 0.9403657567164786 27 P24928,Q9NQC3,Q9NQ50 3 |
| Vitamin d receptor pathway 0.4148559963282598 0.5416033515921119 0.5880917824590619 1.0 0.9403657567164786 13 Q5VV42,Q96KA5,Q92604,P08183 4 |
| Proximal tubule transport 0.4431573212064585 0.5318472452332251 0.5948317976794621 1.0 0.9403657567164786 9 P05023 1 |
| Disorders of folate metabolism and transport 0.4489258560646437 0.5046988692782044 0.6137703553588509 1.0 0.9403657567164786 7 Q99707,P00374 2 |
| Cholesterol biosynthesis pathway 0.4002277211031255 0.4581761044823572 0.6468259259002975 1.0 0.9403657567164786 13 Q15800,P14324,Q16850,Q14534 4 |
| Angiopoietinlike protein 8 regulatory pathway 0.3240961867236641 0.4431249692979214 0.6576753455274336 1.0 0.9403657567164786 24 O00767,Q15418,P51812 3 |
| Spinal cord injury 0.3701865557888981 0.4402985367269398 0.6597209003997526 1.0 0.9403657567164786 16 Q9NQC3,Q08722 2 |
| Dna replication 0.3201281374177047 0.4390916204376351 0.6605951505796157 1.0 0.9403657567164786 27 Q14566,Q9Y619 2 |
| Folate metabolism 0.3964743838984198 0.437135377344939 0.6620131721558584 1.0 0.9403657567164786 13 P34897,Q8WTV0,Q99707,P00374 4 |
| Ethanol effects on histone modifications 0.4138252999578202 0.4160381149729756 0.6773821128889888 1.0 0.9403657567164786 10 P41440,Q99707,P00374 3 |
| Myometrial relaxation and contraction pathways 0.3544092523741016 0.4033396999343429 0.6866983401037434 1.0 0.9443819361143228 17 P16615,Q13555,P78417 3 |
| Ciliopathies 0.3431779471149999 0.3980310190785869 0.6906073208485812 1.0 0.9443819361143228 18 Q10713,Q13432 2 |
| Phosphodiesterases in neuronal function 0.7325033647375618 0.3955079280626848 0.6924680718301461 1.0 0.9443819361143228 2 O43924 1 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4946889189569873 0.3879532363301512 0.698050640477228 1.0 0.9448244716423908 4 P31751 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.4266008759654738 0.3839029049182921 0.7010504132267079 1.0 0.9448244716423908 6 Q13555 1 |
| Estrogen receptor pathway 0.6147775963818545 0.3766917844638416 0.7064026689411074 1.0 0.9448244716423908 3 Q15067 1 |
| Steroid biosynthesis 0.7210632570659496 0.3649686668857478 0.7151347955159866 1.0 0.9448244716423908 2 Q99829 1 |
| Wnt signaling pathway and pluripotency 0.3830942697606405 0.3635619780920357 0.7161851235541183 1.0 0.9448244716423908 13 Q16537,P43034 2 |
| Nuclear receptors metapathway 0.2822052903102917 0.3591966677193591 0.7194479692946836 1.0 0.9448244716423908 45 O00767,Q99735,Q9HCL2,Q15043,P23786,P09601,Q15067,P08183,Q9H2J7 9 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3643322540998569 0.3490440133529933 0.7270562671026117 1.0 0.9465792386135404 15 P50402,P42167 2 |
| Nucleotidebinding oligomerization domain nod pathway 0.412339130657496 0.3384929321503735 0.7349917524212641 1.0 0.9465792386135404 7 Q9P0J0 1 |
| Fatty acid transporters 0.4179755812658373 0.3206660199750411 0.7484635005857538 1.0 0.9495919234154504 5 O95573 1 |
| Fluoropyrimidine activity 0.387611721046665 0.3167105848756046 0.7514632163900692 1.0 0.9495919234154504 11 Q06203,P00374 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.698519515477793 0.3082033002490605 0.7579276413852019 1.0 0.9495919234154504 2 Q7Z434 1 |
| Heme biosynthesis 0.4129125640114275 0.3012133448109426 0.7632518144193818 1.0 0.9495919234154504 5 P36551 1 |
| Vitamin a and carotenoid metabolism 0.4670072655914862 0.2957274872693135 0.767438203781649 1.0 0.9495919234154504 4 Q6NUM9,Q8WTV0 2 |
| Lung fibrosis 0.4050704928828291 0.2932086626650894 0.7693626630873964 1.0 0.9496317389572466 6 P09601 1 |
| Gastric cancer network 2 0.3598390845885437 0.2788959198710536 0.780324699830516 1.0 0.9571550372141464 14 Q86UE4 1 |
| Thermogenesis 0.2951067510363411 0.2384539265290088 0.8115290460542199 1.0 0.9731750755528248 27 Q15418,P23786 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6615074024226139 0.2256862652438573 0.8214454412545864 1.0 0.9804756322815558 2 P08195 1 |
| Vitamin b12 metabolism 0.3801767906543166 0.1961350714776603 0.8445044462694931 1.0 0.9914807105428765 6 Q99707,Q8WTV0 2 |
| Mecp2 and associated rett syndrome 0.290139603216857 0.181414099915878 0.8560425523702369 1.0 0.9981523831984976 20 Q03518,P31943,Q99640,P52597 4 |
| Sulfation biotransformation reaction 0.6312247644683764 0.1687956564845391 0.8659573749265159 1.0 1.0 2 P11413 1 |
| Riboflavin and coq disorders 0.3714499233825097 0.1564161940119581 0.8757049733056523 1.0 1.0 5 O75208 1 |
| Joubert syndrome 0.2994273669705863 0.1231182568303795 0.9020134544070988 1.0 1.0 18 Q10713,Q13432 2 |
| Kit receptor signaling pathway 0.3214117976080881 0.0891716494529052 0.928945496058744 1.0 1.0 14 Q15418,P51812 2 |
| Sarscov2 and covid19 pathway 0.4864852892239498 0.0842804653930974 0.9328334434937776 1.0 1.0 3 Q8WTV0 1 |
| Nrf2 pathway 0.2716440930364976 0.0646016327636001 0.9484911846702156 1.0 1.0 20 Q15043,Q99735,Q9H2J7,P09601 4 |
| Camkk2 pathway 0.3201050154333822 0.0607407299412071 0.9515656937453238 1.0 1.0 13 P09601 1 |
| Reninangiotensinaldosterone system raas 0.4628715660494543 0.052510048931714 0.9581222884930344 1.0 1.0 3 Q13555 1 |
| Erbb signaling pathway 0.3119678460735062 0.0483989304964463 0.961398311647978 1.0 1.0 14 P31751,Q13555 2 |
| Amino acid metabolism pathway excerpt histidine catabolism extension 0.498317631224773 0.0299950809308301 0.9760709762556234 1.0 1.0 2 P00367 1 |
| Relationship between inflammation cox2 and egfr 0.4419823209904268 0.0299551855932982 0.9761027938320914 1.0 1.0 3 P31751 1 |
| Autosomal recessive osteopetrosis pathways 0.4390982503364713 0.0115649939695477 0.9907726755574124 1.0 1.0 2 P51149 1 |
| Wnt signaling 0.3137692612251688 0.0084715007574411 0.993240801186048 1.0 1.0 11 Q13555,P05771 2 |
| Alzheimers disease 0.2835785255716576 0.0039188604195928 0.9968732097785304 1.0 1.0 83 Q9BVA1,P31751,P49721,O95197,P45880,P68371,P16615,Q9NQC3,P07437,P21796,Q99436,P12235,Q13885,Q9Y277 14 |
| Sars coronavirus and innate immunity 0.2886944818304104 0.0037480852263959 0.9970094676671912 1.0 1.0 2 Q7Z434 1 |
| Benzoapyrene metabolism 0.2833109017496554 0.0037354057253907 0.9970195843744614 1.0 1.0 2 P07099 1 |
|
|
